LISINOPRIL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-341 -
Package NDC
76420-341-00 -
Package NDC
76420-341-01 -
Package NDC
76420-341-30 -
Package NDC
76420-341-60 -
Package NDC
76420-341-90 -
Application number
ANDA076164 -
SPL ID
342374a0-645e-e49e-e063-6394a90a2498 -
SPL set ID
db5bfa2f-07b8-4f79-8a40-691da006e2ed -
UNII
E7199S1YWR -
RxCUI
197884 -
RxCUI
205326 -
RxCUI
311353 -
RxCUI
311354 -
RxCUI
314076 -
RxCUI
314077
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Lisinopril
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LISINOPRIL",
"splId": "342374a0-645e-e49e-e063-6394a90a2498",
"labels": [
{
"setId": "db5bfa2f-07b8-4f79-8a40-691da006e2ed",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db5bfa2f-07b8-4f79-8a40-691da006e2ed",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db5bfa2f-07b8-4f79-8a40-691da006e2ed"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (76420-341-00)",
"package_ndc": "76420-341-00",
"identifierStatus": "well-formed",
"marketing_start_date": "20250502"
},
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (76420-341-01)",
"package_ndc": "76420-341-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20250502"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (76420-341-30)",
"package_ndc": "76420-341-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250502"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (76420-341-60)",
"package_ndc": "76420-341-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250502"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (76420-341-90)",
"package_ndc": "76420-341-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250502"
}
],
"productId": "76420-341_342374a0-645e-e49e-e063-6394a90a2498",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "76420-341",
"deaSchedule": null,
"genericName": "Lisinopril",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LISINOPRIL",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA076164",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20111101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"E7199S1YWR"
],
"rxcui": [
"197884",
"205326",
"311353",
"311354",
"314076",
"314077"
],
"spl_set_id": [
"db5bfa2f-07b8-4f79-8a40-691da006e2ed"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-341_342374a0-645e-e49e-e063-6394a90a2498"